Eikon Therapeutics, Inc. Common Stock (EIKN) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EIKN
Eikon Therapeutics, Inc. Common Stock
$7.74HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
SI
Shoulder Innovations, Inc.
$19.70HealthcareDelayed quote: Oct 6, 2026, 11:03 AM EDT
Total return — EIKN vs SI
growth of $100 · dividends reinvested · last 1yEIKN -49.7% (-49.7%/yr)SI +55.9% (+55.9%/yr)SI compounded faster over this window
EIKN SI
EIKN vs SI: by the numbers
- •EIKN is the larger company ($419M vs $409M market cap).
- •Both run net losses; EIKN's is the smaller (0.00% vs -58.33% net margin).
Metrics side by side
Valuation
| Metric | EIKN | SI |
|---|---|---|
| P/S ratio | N/A | 6.80 |
| P/B ratio | 0.90 | 3.29 |
Profitability
| Metric | EIKN | SI |
|---|---|---|
| Gross margin | 0.00% | 77.34% |
| Operating margin | 0.00% | -58.53% |
| Net margin | 0.00% | -58.33% |
| ROE | -69.06% | -28.18% |
| ROIC | -46.16% | -25.26% |
Go deeper
Dig into the metrics
Eikon Therapeutics, Inc. Common Stock ROEShoulder Innovations ROEEikon Therapeutics, Inc. Common Stock operating marginShoulder Innovations operating marginEikon Therapeutics, Inc. Common Stock revenue growthShoulder Innovations revenue growthEikon Therapeutics, Inc. Common Stock free cash flowShoulder Innovations free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.